title: Long-term outcome of a successful cord blood stem cell transplant in mevalonate kinase deficiency.
abstract: Mevalonate kinase deficiency (MKD) is a rare autosomal recessive inborn error of metabolism with an autoinflammatory phenotype that may be expressed as a spectrum of disease phenotypes, from those with prevailing autoinflammatory syndrome and variable response to anti-inflammatory therapies, to mevalonic aciduria, which is associated with dysmorphic features, severe neurologic involvement, and the worst prognosis. We describe a boy, aged 2 years, 10 months, with severe phenotype of mevalonate kinase deficiency who underwent allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-identical unrelated cord blood because his condition had failed to improve with antiinflammatory treatment as first-line therapy and an anticytokine drug as second-line therapy. The child had a sustained remission of febrile attacks and inflammation after transplant, and during a 5-year follow-up period, psychomotor and neurologic development were normal, without signs of underlying disease or late transplant-related effects. This case confirms that allogeneic HSCT is a safe and effective cure for patients affected by MKD in whom anticytokine drugs alone are insufficient for the management of autoinflammatory syndrome and for the unfavorable outcome of the disease.
authors.affiliation: Stem Cell Transplantation Unit, Department of Pediatric Hematology and Oncology, stefano.giardino@libero.it stefanogiardino@ospedale-gaslini.ge.it.
authors.forename: Stefano
authors.initials: S
authors.lastname: Giardino
authors.affiliation: Stem Cell Transplantation Unit, Department of Pediatric Hematology and Oncology.
authors.forename: Edoardo
authors.initials: E
authors.lastname: Lanino
authors.affiliation: Stem Cell Transplantation Unit, Department of Pediatric Hematology and Oncology.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Morreale
authors.affiliation: Reumatology Unit and.
authors.forename: Annalisa
authors.initials: A
authors.lastname: Madeo
authors.affiliation: Rare Diseases Unit, Department of Paediatrics, Istituto G. Gaslini, Genoa, Italy.
authors.forename: Maja
authors.initials: M
authors.lastname: Di Rocco
authors.affiliation: Reumatology Unit and.
authors.forename: Marco
authors.initials: M
authors.lastname: Gattorno
authors.affiliation: Stem Cell Transplantation Unit, Department of Pediatric Hematology and Oncology.
authors.forename: Maura
authors.initials: M
authors.lastname: Faraci
mesh_terms: D002675:Child, Preschool; D036101:Cord Blood Stem Cell Transplantation; D006801:Humans; D008297:Male; D054078:Mevalonate Kinase Deficiency / Q000601:surgery*; D012074:Remission Induction; D016896:Treatment Outcome
keywords: autoinflammatory syndrome; mevalonate kinase deficiency; stem cell transplantation